Ownership history in PEAK6 Group LLC Β· 44 quarters on record
This page tracks every 13F SEC filing in which PEAK6 Group LLC reported a position in MEDNAX INC COM COM (MD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π PEAK6 Group LLC underperformed the S&P 500 by β1.0% annually on this MD position. Timing score: 55% (22/40 decisions correct). Average cost basis: $40.97. Maximum drawdown during holding period: β43.8%.
β‘οΈ Roughly in line with S&P 500 (Β±1% alpha range).
43 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
22 of 40 add/trim decisions correct
Best entry: $14.73 (2009 Q1) Β· Worst: $72.51 (2015 Q1)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
18 adds Β· 23 trims. Bought during 3 of 8 down-price quarters. π Predominantly trimming β distribution phase.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size